A
new health services business is looking to catch what its founder sees as an emerging third wave in the clinical application of genomics.
“We understand the clinical market space, and we understand the technology market space, and we try to bring those two together in the most productive way possible,” according to Mark S. Boguski, M.D., Ph.D., F.C.A.P., a faculty member at Harvard Medical School’s Center for Biomedical Informatics and Beth Israel Deaconess Medical Center.
To read the full, original article click on this link:
